Shareholding18 Jun 2026, 03:32 pm
Cohance Lifesciences: Promoters Disclose Share Encumbrance
AI Summary
Cohance Lifesciences Limited (formerly Suven Pharmaceuticals) has received disclosures under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, from its promoters Jusmiral Holdings Ltd and Berhyanda Ltd, along with their respective subsidiaries Jusmiral Midco Ltd and Berhyanda Midco Ltd. These disclosures pertain to encumbrances created on shares, including restrictions on disposal and creation of security, as per a Notes Purchase Agreement and subsequent share pledge deeds effective from June 18, 2024. The filings indicate a complex structure involving multiple entities and financial agreements that impact the promoters' shareholding.
Key Highlights
- Promoters Jusmiral Holdings and Berhyanda disclosed share encumbrances.
- Encumbrances include disposal restrictions and security creation.
- Agreements are governed by a Notes Purchase Agreement and share pledges.
- Pledges became effective from June 18, 2024.
- Disclosures filed under SEBI (SAST) Regulations, 2011.
Price Impact
More from SUVENPHAR